# PatchRx

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/patchrx

- Industry: Medical Devices & Equipment
- Headquarters: Tulsa, US
- Website: www.patchrx.io
- Total disclosed funding: $9.2M
- Latest round: Series A (Aug 30, 2023)
- Investors on record: 6

## About

Founded in 2019 and headquartered in Tulsa, US, PatchRx, Inc. specializes in enhancing medication adherence with its advanced technology. The company was co-founded by Andrew Aertker and Gavin Buchanan. In August 2025, Custom Health Inc. acquired PatchRx, Inc. from Cortado Ventures, Atento Capita, Gaingels, Forum Ventures, Plains Venture Partners, and Vast Ventures. Financial terms of the transaction were not disclosed. PatchRx provides a smart-cap enabled platform designed to enhance medication adherence through proactive care interventions. The core offering includes the universally-fit smart pill bottle cap, referred to as PatchCap, which tracks and monitors patient medication usage by recording pill-bottle-opening events. By collecting and analyzing data from these smart caps, the platform generates insights into a patient's medication history and adherence patterns, facilitating more effective care management. The system is particularly aimed at patients requiring oversight for one or two critical or high-risk medications, enabling healthcare providers to improve treatment outcomes. The key customer base comprises clinics and healthcare providers located primarily in the United States, with the potential for global application as the technology gains recognition.PatchRx generates revenue through a fee-for-service model that includes the sale of its PatchCaps and Gateways, alongside integration services via API for healthcare providers. The transactions typically involve direct sales to healthcare providers, who then incorporate PatchRx's solutions into their patient care workflow. Pricing structures are determined through contractual agreements, encompassing fees for shipping directly to patients or to the provider's facility, with a small fee for patient shipments included in the contract. Support services during integration, as well as ongoing customer support, are also part of the revenue model, ensuring a comprehensive service for clients. This strategic approach allows PatchRx to maintain a robust revenue stream while enhancing patient engagement through its innovative technology. The August 2025 acquisition aims to accelerate PatchRx, Inc.'s mission to link patients, providers, and payors through real-time data, smart dispensing, and tailored engagement.

## Funding rounds

- Series A, Aug 30, 2023, $8M — Vast Ventures, Forum Ventures, Plains Venture Partners, Cortado Ventures, Atento Capital
- Seed, Jul 7, 2021, $1.2M — Gaingels, Cortado Ventures, Atento Capital
- Seed, May 29, 2020 — Cortado Ventures

## Investors

- Cortado Ventures (https://capitalatlas.ai/funds/cortado-ventures) — Seed, Series A
- Gaingels (https://capitalatlas.ai/funds/gaingels) — Seed
- Atento Capital (https://capitalatlas.ai/funds/atento-capital) — Seed, Series A
- Vast Ventures (https://capitalatlas.ai/funds/vast-ventures) — Series A
- Forum Ventures (https://capitalatlas.ai/funds/forum-ventures) — Series A
- Plains Venture Partners (https://capitalatlas.ai/funds/plains-venture-partners) — Series A